Clinical Trials List
2024-02-01 - 2028-04-15
Others
Recruiting2
ICD-10C18.8
Malignant neoplasm of overlapping sites of colon
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.8
Malignant neoplasm of other specified sites of large intestine
-
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 黃怡菁 Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Wu Chen Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
150 participants
